Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BAX Baxter International | ABT Abbott Laboratories |
|---|---|---|
| Price | $23.53 -0.8% | $102.36 +0.3% |
| StockIQ Score | 41D Weak Risk: High | 51C- Moderate Risk: Medium |
| Technical | 33F | 23F |
| Fundamental | 23F | 72B |
| Growth | 40D | 45D+ |
| Fair Value | 50C- | 38F |
| News | 86A | 92A+ |
| Quality | 42D | 63C+ |
| Risk | 42D | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
BAX scores higher in technical (33 vs 23) and valuation (50 vs 38), but its overall investorScore is lower at 41 versus ABT’s 51. ABT also dominates fundamentals (72 vs 23) and growth (45 vs 40), reflecting a stronger fundamental and growth profile. The rating mirrors this, with ABT marked MODERATE while BAX is WEAK.